Catalyst Pharmaceuticals Inc (CPRX)

Current ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total current assets	US$ in thousands	623,609	538,998	474,429	404,602	219,329	192,017	240,968	198,911	320,797	276,310	242,558	221,191	210,106	192,795	176,305	161,533	159,244	143,342	131,164	116,944
Total current liabilities	US$ in thousands	120,678	105,395	92,318	79,566	76,063	57,806	52,503	56,709	57,588	44,681	22,488	22,938	27,063	20,614	16,135	14,436	22,756	18,232	20,210	17,636
Current ratio		5.17	5.11	5.14	5.09	2.88	3.32	4.59	3.51	5.57	6.18	10.79	9.64	7.76	9.35	10.93	11.19	7.00	7.86	6.49	6.63

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $623,609K ÷ $120,678K
= 5.17

The current ratio of Catalyst Pharmaceuticals Inc has shown fluctuations over the reviewed periods. The current ratio measures the company's ability to cover its short-term liabilities with its short-term assets. A higher current ratio is generally favorable as it indicates the company has more current assets than current liabilities.

In the first quarter of 2020, the current ratio was 6.63, indicating a strong position. Subsequently, the ratio remained above 6 in the following quarters. By March 2021, the ratio peaked at 11.19, suggesting a significant increase in current assets compared to short-term obligations.

However, from September 2022 onwards, the current ratio started to decline, falling to 2.88 by the end of December 2023. This significant decrease may raise concerns about the company's liquidity and ability to meet short-term debt obligations.

In the following year, the ratio improved slightly but remained below previous levels, reflecting a current ratio of around 5 in the last reported period (December 31, 2024).

Overall, the current ratio of Catalyst Pharmaceuticals Inc has shown variability, indicating a fluctuating ability to cover short-term liabilities with current assets, with recent trends suggesting a need for monitoring and further analysis of the company's liquidity position.